Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)

Journal of Pineal Research

Volumn 49, Issue 3, 2010, Pages 248-255

  Leja Szpak, Anna ^a   Jaworek, Jolanta ^a   Pierzchalski, Piotr ^a   Reiter, Russel J ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

apoptosis; Bcl 2 Bax; human pancreatic carcinoma; melatonin; pancreatic carcinoma cells

Indexed keywords

CASPASE 9; CYTOPLASM PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; LUZINDOLE; MELATONIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INCUBATION TIME; MITOCHONDRIAL MEMBRANE; PANCREAS CARCINOMA; PROTEIN EXPRESSION; PROTEIN ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; HSP27 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MELATONIN; PANCREATIC NEOPLASMS; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; TRYPTAMINES;

EID: 77956301403     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00789.x     Document Type: Article

References (71)

1. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006 24 : 87 94.
2. Han SS, Jang JY, Kim SW, Kim WH, Lee KU, Park YH. Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 2006 32 : 271 275.
3. Talar-Wojnarowska R, Malecka-Panas E. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications. Med Sci Monit 2006 12 : RA186 RA193.
4. Chowdhury I, Tharakan B, Bhat GK. Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol 2008 151 : 10 27.
5. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003 22 : 8543 8567.
6. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004 23 : 2950 2966.
7. Autret A, Martin SJ. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 2009 36 : 355 363.
8. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007 19 : 488 496.
9. Fulda S. Tumor resistance to apoptosis. Int J Cancer 2009 124 : 511 515.
10. Lee WY, Jin YT, Tzeng CC. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Anticancer Res 1996 16 : 3007 3012.
11. Kapranos N, Karaiosifidi H, Valavanis C, Kouri E, Vasilaros S. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Anticancer Res 1997 17 : 2499 2505.
12. Okumura K, Huang S, Sinicrope FA. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737. Clin Cancer Res 2008 14 : 8132 8142.
13. Matsushima H, Goto T, Hosaka Y, Kitamura T, Kawabe K. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation. Cancer 1999 85 : 1822 1827.
14. Sun CY, Wang BL, Hu CQ et al. Expression of the Bcl-2 gene and its significance in human pancreatic carcinoma. Hepatobiliary Pancreat Dis Int 2002 1 : 306 318.
15. Mäkinen K, Hakala T, Lipponen P, Alhava E, Eskelinen M. Clinical contribution of Bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Anticancer Res 1998 18 : 615 618.
16. Nio Y, Iguchi C, Yamasawa K et al. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas. Pancreas 2001 22 : 230 239.
17. Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS, Neoptolemos JP. Detailed tissue expression of Bcl-2, Bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 2001 1 : 254 262.
18. Campani D, Esposito I, Boggi U et al. Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 2001 194 : 444 450.
19. Li X, Ding X, Adrian TE. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation and GADD expression. Pancreas 2003 27 : 174 179.
20. Tong WG, Ding XZ, Witt RC, Adrian TE. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 2002 1 : 929 935.
21. Hinz S, Trauzold A, Boenicke C et al. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene 2000 19 : 5477 5486.
22. Jiang PH, Motoo Y, Sawabu N, Minamoto T. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 2006 12 : 1597 1602.
23. Xu ZW, Friess H, Büchler MW, Solioz M. Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. Cancer Chemother Pharmacol 2002 49 : 504 510.
24. Han D, Ybanez MD, Ahmadi S, Yeh K, Kaplowitz N. Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 2009 11 : 2245 2263.
25. Pan JS, Hong MZ, Ren JL. Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol 2009 15 : 1702 1707.
26. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya SA. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004 279 : 34643 34654.
27. Edderkaoui M, Hong P, Vaquero EC et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am J Physiol Gastrointest Liver Physiol 2005 289 : G1137 G1147.
28. Konturek SJ, Konturek PCH, Brzozowski T. Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. J Physiol Pharmacol 2006 57 : 51 66.
29. Jaworek J, Leja-Szpak A, Bonior J et al. Protective effect of melatonin and its precursor l-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003 34 : 40 52.
30. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006 57 : 83 96.
31. Lopez A, Garcia JA, Escames G et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009 46 : 188 198.
32. Gitto E, Pellegrino S, Gitto P, Barberi I, Reiter RJ. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009 46 : 128 139.
33. Lahiri S, Singh P, Singh S, Rasheed N, Palit G, Pant KK. Melatonin protects against experimental reflux esophagitis. J Pineal Res 2009 46 : 207 213.
34. Lerner AB, Case JD, Takahashi Y. Isolation of melatonin, pineal factor that lightens melanocytes. J Am Chem Soc 1958 80 : 258.
35. Reiter RJ, Richardson BA, Hurlbut EC. Pineal, retinal and Harderian gland melatonin in a diurnal species, the Richardson's ground squirrel (Spermophilus richardsonii). Neurosci Lett 1981 22 : 285 288.
36. Bubenik GA. Gastrointestinal melatonin, localization, function and clinical relevance. Dig Dis Sci 2002 10 : 2336 2348.
37. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptor localisation, molecular pharmacology and physiological significance. Neurochem Int 1994 24 : 101 146.
38. Konturek SJ, Konturek PC, Brzozowska I et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 2007 58 : 381 405.
39. Mirick DK, Davis S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers Prev 2008 17 : 3306 3313.
40. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994 91 : 1824 1828.
41. Malpaux B, Thiéry JC, Chemineau P. Melatonin and the seasonal control of reproduction. Reprod Nutr Dev 1999 39 : 355 366.
42. Couto-Moraes R, Palermo-Neto J, Markus RP. The immune-pineal axis: stress as a modulator of pineal gland function. Ann N Y Acad Sci 2009 1153 : 193 202.
43. Lardone PJ, Carrillo-Vico A, Molinero P, Rubio A, Guerrero JM. A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production. Cell Mol Life Sci 2009 66 : 516 525.
44. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009 44 : 175.
45. Peyrot F, Ducrocq C. Potential role of tryptophan derivates in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
46. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes; a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
47. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009 47 : 109 126.
48. Fischer TW, Zmijewski MA, Zbytek B et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 2006 29 : 665 672.
49. Yang QH, Xu JN, Xu RK, Pang SF. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J Pineal Res 2007 42 : 172 179.
50. Sainz RM, Mayo JC, Tan DX, Leon J, Manchester L, Reiter RJ. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 2005 63 : 29 43.
51. Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 2009 47 : 8 14.
52. Girgert R, Hanf V, Emons G, Gründker C. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009 47 : 23 31.
53. Kobayashi Y, Itoh MT, Kondo H et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer. J Pineal Res 2003 35 : 71 84.
54. Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Rabelo O, Gonzalez P, Gonzalez-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008 45 : 532 540.
55. Subramanian P, Mirunalini S, Dakshayani KB, Pandi-Perumal SR, Trakht I, Cardinali DP. Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine. J Pineal Res 2007 43 : 305 312.
56. Tanaka T, Yasui Y, Tanaka M, Tanaka T, Oyama T, Rahman KM. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem Biol Interact 2009 177 : 128 136.
57. García-Navarro A, González-Puga C, Escames G et al. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res 2007 43 : 195 205.
58. Bejarano I, Redondo PC, Espino J et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009 46 : 392 400.
59. Cucina A, Proietti S, D'anselmi F. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res 2009 46 : 172 180.
60. Jang SS, Kim WD, Park WY. Melatonin exerts differential actions on X-ray radiation-induced apoptosis in normal mice splenocytes and Jurkat leukemia cells. J Pineal Res 2009 47 : 147 155.
61. Cabrera J, Quintana J, Reiter RJ, Loro J, Cabrera F, Estevez F. Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: possible involvement of the MT2 receptor. J Pineal Res 2003 35 : 231 238.
62. Lanneau D, De Thonel A, Maurel S, Didelot C, Garrido C. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 2007 1 : 53 60.
63. Leja-Szpak A, Jaworek J, Szklarczyk J, Konturek SJ, Pawlik WW. Melatonin stimulates HSP27 phosphorylation in human pancreatic carcinoma cells (PANC-1). J Physiol Pharmacol 2007 58 : 177 188.
64. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 2002 22 : 816 834.
65. Rocchi P, Jugpal P, So A et al. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. BJU Int 2006 98 : 1082 1089.
66. Radogna F, Cristofanon S, Paternoster L et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008 44 : 316 325.
67. Lissoni P, Brivio F, Fumagalli L et al. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Anticancer Res 2008 28 : 1377 1381.
68. Lissoni P, Fumagalli L, Paolorossi F, Rovelli F, Roselli MG, Maestroni GJ. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin. J Biol Regul Homeost Agents 1997 11 : 119 122.
69. Lissoni P, Malugani F, Brivio F et al. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study. Neuro Endocrinol Lett 2003 24 : 259 262.
70. Ruiz-Rabelo JF, Vázquez R, Perea MD et al. Beneficial properties of melatonin in an experimental model of pancreatic cancer. J Pineal Res 2007 43 : 270 275.
71. Ekmecioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006 60 : 97 108.